| PUBCHEM ID |
23678357
|
| UNII |
0KSO632QIJ
|
| Preferred Term |
MOCIMYCIN SODIUM
|
| CAS |
53152-67-3
|
| INCHIKEY |
ZOYOPUDQXPJARV-GAMAPSDWSA-M
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC[C@H]([C@]([C@@H]([C@H](C1(C)C)O)O)(O)O[C@@H]1/C=C/C=C\C)C(NC/C=C/C=C(\C)/[C@@H]([C@H](C)[C@H]([C@@H]([C@@H]1O)O)O[C@H]1/C=C/C=C/C=C(\C)/C(C(C(NC=C1)=O)=C1O)=O)OC)=O
|
| Total Surface Area |
620,03
|
| Relative PSA |
0,27521
|
| TPSA |
224,34
|
| cLogS |
-4,628
|
| MW |
796,951
|
| cLogP |
3,0901
|
| H-Acceptors |
14
|
| H-Donors |
8
|
| Ro5 violations |
3
|
| Druglikeness |
0,43785
|
| DrugScore |
0,307544584143956
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,3009
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,9532
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5601
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,7251
|
| Carcinogenicity (Three-class) |
Non-required
|